Cargando…
EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide
The EULAR Sjögren's syndrome (SS) disease activity index (ESSDAI) is a systemic disease activity index that was designed to measure disease activity in patients with primary SS. With the growing use of the ESSDAI, some domains appear to be more challenging to rate than others. The ESSDAI is now...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613159/ https://www.ncbi.nlm.nih.gov/pubmed/26509054 http://dx.doi.org/10.1136/rmdopen-2014-000022 |
_version_ | 1782396225463517184 |
---|---|
author | Seror, Raphaèle Bowman, Simon J Brito-Zeron, Pilar Theander, Elke Bootsma, Hendrika Tzioufas, Athanasios Gottenberg, Jacques-Eric Ramos-Casals, Manel Dörner, Thomas Ravaud, Philippe Vitali, Claudio Mariette, Xavier |
author_facet | Seror, Raphaèle Bowman, Simon J Brito-Zeron, Pilar Theander, Elke Bootsma, Hendrika Tzioufas, Athanasios Gottenberg, Jacques-Eric Ramos-Casals, Manel Dörner, Thomas Ravaud, Philippe Vitali, Claudio Mariette, Xavier |
author_sort | Seror, Raphaèle |
collection | PubMed |
description | The EULAR Sjögren's syndrome (SS) disease activity index (ESSDAI) is a systemic disease activity index that was designed to measure disease activity in patients with primary SS. With the growing use of the ESSDAI, some domains appear to be more challenging to rate than others. The ESSDAI is now in use as a gold standard to measure disease activity in clinical studies, and as an outcome measure, even a primary outcome measure, in current randomised clinical trials. Therefore, ensuring an accurate and reproducible rating of each domain, by providing a more detailed definition of each domain, has emerged as an urgent need. The purpose of the present article is to provide a user guide for the ESSDAI. This guide provides definitions and precisions on the rating of each domain. It also includes some minor improvement of the score to integrate advance in knowledge of disease manifestations. This user guide may help clinicians to use the ESSDAI, and increase the reliability of rating and consequently of the ability to detect true changes over time. This better appraisal of ESSDAI items, along with the recent definition of disease activity levels and minimal clinically important change, will improve the assessment of patients with primary SS and facilitate the demonstration of effectiveness of treatment for patients with primary SS. |
format | Online Article Text |
id | pubmed-4613159 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-46131592015-10-27 EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide Seror, Raphaèle Bowman, Simon J Brito-Zeron, Pilar Theander, Elke Bootsma, Hendrika Tzioufas, Athanasios Gottenberg, Jacques-Eric Ramos-Casals, Manel Dörner, Thomas Ravaud, Philippe Vitali, Claudio Mariette, Xavier RMD Open Connective Tissue Diseases The EULAR Sjögren's syndrome (SS) disease activity index (ESSDAI) is a systemic disease activity index that was designed to measure disease activity in patients with primary SS. With the growing use of the ESSDAI, some domains appear to be more challenging to rate than others. The ESSDAI is now in use as a gold standard to measure disease activity in clinical studies, and as an outcome measure, even a primary outcome measure, in current randomised clinical trials. Therefore, ensuring an accurate and reproducible rating of each domain, by providing a more detailed definition of each domain, has emerged as an urgent need. The purpose of the present article is to provide a user guide for the ESSDAI. This guide provides definitions and precisions on the rating of each domain. It also includes some minor improvement of the score to integrate advance in knowledge of disease manifestations. This user guide may help clinicians to use the ESSDAI, and increase the reliability of rating and consequently of the ability to detect true changes over time. This better appraisal of ESSDAI items, along with the recent definition of disease activity levels and minimal clinically important change, will improve the assessment of patients with primary SS and facilitate the demonstration of effectiveness of treatment for patients with primary SS. BMJ Publishing Group 2015-02-20 /pmc/articles/PMC4613159/ /pubmed/26509054 http://dx.doi.org/10.1136/rmdopen-2014-000022 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Connective Tissue Diseases Seror, Raphaèle Bowman, Simon J Brito-Zeron, Pilar Theander, Elke Bootsma, Hendrika Tzioufas, Athanasios Gottenberg, Jacques-Eric Ramos-Casals, Manel Dörner, Thomas Ravaud, Philippe Vitali, Claudio Mariette, Xavier EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide |
title | EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide |
title_full | EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide |
title_fullStr | EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide |
title_full_unstemmed | EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide |
title_short | EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide |
title_sort | eular sjögren's syndrome disease activity index (essdai): a user guide |
topic | Connective Tissue Diseases |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613159/ https://www.ncbi.nlm.nih.gov/pubmed/26509054 http://dx.doi.org/10.1136/rmdopen-2014-000022 |
work_keys_str_mv | AT serorraphaele eularsjogrenssyndromediseaseactivityindexessdaiauserguide AT bowmansimonj eularsjogrenssyndromediseaseactivityindexessdaiauserguide AT britozeronpilar eularsjogrenssyndromediseaseactivityindexessdaiauserguide AT theanderelke eularsjogrenssyndromediseaseactivityindexessdaiauserguide AT bootsmahendrika eularsjogrenssyndromediseaseactivityindexessdaiauserguide AT tzioufasathanasios eularsjogrenssyndromediseaseactivityindexessdaiauserguide AT gottenbergjacqueseric eularsjogrenssyndromediseaseactivityindexessdaiauserguide AT ramoscasalsmanel eularsjogrenssyndromediseaseactivityindexessdaiauserguide AT dornerthomas eularsjogrenssyndromediseaseactivityindexessdaiauserguide AT ravaudphilippe eularsjogrenssyndromediseaseactivityindexessdaiauserguide AT vitaliclaudio eularsjogrenssyndromediseaseactivityindexessdaiauserguide AT mariettexavier eularsjogrenssyndromediseaseactivityindexessdaiauserguide |